SlideShare uma empresa Scribd logo
1 de 17
Baixar para ler offline
Reconfiguring primary care for
  the era of chronic diseases
      Margaret E. Kruk, MD MPH
  Columbia University Mailman School
           of Public Health
           February 4, 2013
A few numbers

• 44 million
• 80%
• 1 in 3



                          1
A few numbers
• 44 million deaths from CVD,
  diabetes, cancer, chronic
  respiratory disease in 2010
• 80% of NCD deaths in low- and
  middle income countries
• 1 in 3 NCD deaths in LMICs are
  under the age of 60              2
Shifting epidemiology:
                         Brazil 1930-2004




PAHO/WHO. Scaling up Primary Health Care Interventions for Chronic Disease Prevention and Control. 35th Annual International
Conference of the Global Health Council. Washington, DC: PAHO/WHO; 2008.                                                 3
Primary care
•   first-contact care
•   promotes ease of access
•   care for a broad range of health needs
•   continuity
•   involvement of family and community

                                             4
Primary care
• first-contact care
• promotes ease of access     Ideal
• care for a broad range of   platform
  health needs                for
• continuity                  tackling
                              NCDs
• involvement of family
  and community
                                   5
Many NCD services can be
     provided in primary care
• Primary prevention: Hepatitis B and HPV
  immunization, smoking cessation
• Diagnosis: BP, cholesterol, glucose testing,
  mammography, opportunistic screening for
  depression



                                             6
Many NCD services can be
     provided in primary care
• Management: CVD therapy, inhaled
  corticosteroids/beta-2 agonists,
  hypoglycemics, antidepressants, retinopathy
  screening
• Palliation: home-based care for terminal
  cancer, opiate therapy


                                            7
But primary care in LMICs not able
      to meet NCD challenge

Historic
orientation to
infectious
diseases and
maternal and
child health

                               8
But primary care in LMICs not able
      to meet NCD challenge

Chronic
underfunding
and human
resource crisis




                               9
The NCD imperative
• Integration and continuity of care
• Innovative service delivery
• Inclusion of patients and communities
• Information and communication
and
• Evaluation for accountability

                                          10
Integration and continuity
• Reorganize of care delivery with patient as
  the central node
• Move from vertical programming to investing
  in health systems
• Borrow from HIV care: a chronic,
  communicable disease
• Team based care (e.g., Brazil’s family health
  teams)
• Integration with referral care
                                            11
Innovative service delivery
• Shift tasks to non-physicians (Cameroon’s
  nurse-led CVD program)
• Use algorithms and clinical guidelines
• Diagnose at the point of care (e.g., Peru’s
  see and treat cervical cancer screening)



                                                12
Inclusion of patients and
            communities
• Reduce financial barriers to care for NCDs
  (e.g., diabetes in Cameroon, CCTs in
  Mexico)
• Improve fit between patient expectations
  and reality in health service provision
• Reach out to community and engage peers


                                               13
Information and communication
• Use mobile phones to promote healthy
  lifestyles (e.g., smoking cessation in
  Britain)
• Use mobile and internet technology to
  bridge distance between home and primary
  health clinic (e.g., text test results, appt
  reminders)

                                                 14
Evaluation is a crucial
           underpinning
• Learning what works across different
  settings
• Making necessary course corrections
• Enhancing accountability to funders and
  patients



                                            15
Need for a reset of primary care
to realize its potential to tackle
  NCDs in low- and middle-
        income countries


                                     16

Mais conteúdo relacionado

Mais procurados

Public health aspects of migration - Communicable diseases, preparedness and ...
Public health aspects of migration - Communicable diseases, preparedness and ...Public health aspects of migration - Communicable diseases, preparedness and ...
Public health aspects of migration - Communicable diseases, preparedness and ...WHO Regional Office for Europe
 
Moving towards a common understanding of the public health aspects of large-s...
Moving towards a common understanding of the public health aspects of large-s...Moving towards a common understanding of the public health aspects of large-s...
Moving towards a common understanding of the public health aspects of large-s...WHO Regional Office for Europe
 
Integrating CVD screening and treatment into HIV service delivery points_Lamptey
Integrating CVD screening and treatment into HIV service delivery points_LampteyIntegrating CVD screening and treatment into HIV service delivery points_Lamptey
Integrating CVD screening and treatment into HIV service delivery points_LampteyCORE Group
 
Η διαχείριση των μειζόνων συμπεριφορικών παραγόντων κινδύνου στην ΠΦΥ
Η διαχείριση των μειζόνων συμπεριφορικών παραγόντων κινδύνου στην ΠΦΥΗ διαχείριση των μειζόνων συμπεριφορικών παραγόντων κινδύνου στην ΠΦΥ
Η διαχείριση των μειζόνων συμπεριφορικών παραγόντων κινδύνου στην ΠΦΥEvangelos Fragkoulis
 
NACP / STD CONTROL PROGRAM
NACP / STD CONTROL PROGRAMNACP / STD CONTROL PROGRAM
NACP / STD CONTROL PROGRAMfrancis milan
 
Delivering Healthcare (Part 2) Lecture B
Delivering Healthcare (Part 2) Lecture BDelivering Healthcare (Part 2) Lecture B
Delivering Healthcare (Part 2) Lecture BCMDLearning
 
Epidemiology of disease burden in Uganda.
Epidemiology of disease burden in Uganda.Epidemiology of disease burden in Uganda.
Epidemiology of disease burden in Uganda.MAK1stABMSC2019
 
Health promotion -National Vector Borne Disease Control Programme
Health promotion -National Vector Borne Disease Control ProgrammeHealth promotion -National Vector Borne Disease Control Programme
Health promotion -National Vector Borne Disease Control ProgrammeMohan Jangwal
 
Public Health Aspects of Migration in the WHO European Region. Keynote Speec...
Public Health Aspects of Migration in the WHO European Region.  Keynote Speec...Public Health Aspects of Migration in the WHO European Region.  Keynote Speec...
Public Health Aspects of Migration in the WHO European Region. Keynote Speec...WHO Regional Office for Europe
 
STREAM THREE: Engaging Medical Students in Rare Disease - Jessie Kulaga-Yosko...
STREAM THREE: Engaging Medical Students in Rare Disease - Jessie Kulaga-Yosko...STREAM THREE: Engaging Medical Students in Rare Disease - Jessie Kulaga-Yosko...
STREAM THREE: Engaging Medical Students in Rare Disease - Jessie Kulaga-Yosko...Canadian Organization for Rare Disorders
 
1 attitude of health care workers to patient
1 attitude of health care workers to patient1 attitude of health care workers to patient
1 attitude of health care workers to patientDHATTALUCK
 
Homeopathic Medical System
Homeopathic Medical SystemHomeopathic Medical System
Homeopathic Medical SystemAbdul Nasir
 
NATIONAL AIDS CONTROL PROGRAMME IN INDIA
NATIONAL AIDS CONTROL PROGRAMME IN INDIANATIONAL AIDS CONTROL PROGRAMME IN INDIA
NATIONAL AIDS CONTROL PROGRAMME IN INDIABharat Masal
 
Elimination and eradication of tetanus
Elimination and eradication of tetanusElimination and eradication of tetanus
Elimination and eradication of tetanusahmed sakandary
 

Mais procurados (20)

Public health aspects of migration - Communicable diseases, preparedness and ...
Public health aspects of migration - Communicable diseases, preparedness and ...Public health aspects of migration - Communicable diseases, preparedness and ...
Public health aspects of migration - Communicable diseases, preparedness and ...
 
Moving towards a common understanding of the public health aspects of large-s...
Moving towards a common understanding of the public health aspects of large-s...Moving towards a common understanding of the public health aspects of large-s...
Moving towards a common understanding of the public health aspects of large-s...
 
Integrating CVD screening and treatment into HIV service delivery points_Lamptey
Integrating CVD screening and treatment into HIV service delivery points_LampteyIntegrating CVD screening and treatment into HIV service delivery points_Lamptey
Integrating CVD screening and treatment into HIV service delivery points_Lamptey
 
Η διαχείριση των μειζόνων συμπεριφορικών παραγόντων κινδύνου στην ΠΦΥ
Η διαχείριση των μειζόνων συμπεριφορικών παραγόντων κινδύνου στην ΠΦΥΗ διαχείριση των μειζόνων συμπεριφορικών παραγόντων κινδύνου στην ΠΦΥ
Η διαχείριση των μειζόνων συμπεριφορικών παραγόντων κινδύνου στην ΠΦΥ
 
NACP / STD CONTROL PROGRAM
NACP / STD CONTROL PROGRAMNACP / STD CONTROL PROGRAM
NACP / STD CONTROL PROGRAM
 
Delivering Healthcare (Part 2) Lecture B
Delivering Healthcare (Part 2) Lecture BDelivering Healthcare (Part 2) Lecture B
Delivering Healthcare (Part 2) Lecture B
 
Epidemiology of disease burden in Uganda.
Epidemiology of disease burden in Uganda.Epidemiology of disease burden in Uganda.
Epidemiology of disease burden in Uganda.
 
Health promotion -National Vector Borne Disease Control Programme
Health promotion -National Vector Borne Disease Control ProgrammeHealth promotion -National Vector Borne Disease Control Programme
Health promotion -National Vector Borne Disease Control Programme
 
Social and Behavioural Sciences and Public Health: Where Next?
Social and Behavioural Sciences and Public Health: Where Next?Social and Behavioural Sciences and Public Health: Where Next?
Social and Behavioural Sciences and Public Health: Where Next?
 
Public Health Aspects of Migration in the WHO European Region. Keynote Speec...
Public Health Aspects of Migration in the WHO European Region.  Keynote Speec...Public Health Aspects of Migration in the WHO European Region.  Keynote Speec...
Public Health Aspects of Migration in the WHO European Region. Keynote Speec...
 
STREAM THREE: Engaging Medical Students in Rare Disease - Jessie Kulaga-Yosko...
STREAM THREE: Engaging Medical Students in Rare Disease - Jessie Kulaga-Yosko...STREAM THREE: Engaging Medical Students in Rare Disease - Jessie Kulaga-Yosko...
STREAM THREE: Engaging Medical Students in Rare Disease - Jessie Kulaga-Yosko...
 
1 attitude of health care workers to patient
1 attitude of health care workers to patient1 attitude of health care workers to patient
1 attitude of health care workers to patient
 
Noncommunicable Conditions
Noncommunicable ConditionsNoncommunicable Conditions
Noncommunicable Conditions
 
Abstract students kap
Abstract students kapAbstract students kap
Abstract students kap
 
Mental Health Problems among Prisoners
Mental Health Problems among Prisoners Mental Health Problems among Prisoners
Mental Health Problems among Prisoners
 
Directly observed treatment short course
Directly observed treatment short courseDirectly observed treatment short course
Directly observed treatment short course
 
National AIDS Control Programme
National AIDS Control ProgrammeNational AIDS Control Programme
National AIDS Control Programme
 
Homeopathic Medical System
Homeopathic Medical SystemHomeopathic Medical System
Homeopathic Medical System
 
NATIONAL AIDS CONTROL PROGRAMME IN INDIA
NATIONAL AIDS CONTROL PROGRAMME IN INDIANATIONAL AIDS CONTROL PROGRAMME IN INDIA
NATIONAL AIDS CONTROL PROGRAMME IN INDIA
 
Elimination and eradication of tetanus
Elimination and eradication of tetanusElimination and eradication of tetanus
Elimination and eradication of tetanus
 

Destaque

Особая группа лекарственных препаратов - биоаналоги
Особая группа лекарственных препаратов - биоаналогиОсобая группа лекарственных препаратов - биоаналоги
Особая группа лекарственных препаратов - биоаналогиАнастасия Мингазова
 

Destaque (9)

17. Dr. Barry Cherney - International Alliance for Biological Standardization
17. Dr. Barry Cherney - International Alliance for Biological Standardization 17. Dr. Barry Cherney - International Alliance for Biological Standardization
17. Dr. Barry Cherney - International Alliance for Biological Standardization
 
Pharmacovigilance: Partnering for Patient Safety
Pharmacovigilance: Partnering for Patient SafetyPharmacovigilance: Partnering for Patient Safety
Pharmacovigilance: Partnering for Patient Safety
 
8. Dr. Alex Kudrin - Medicines and Healthcare Products Regulatory Agency (UK)
8. Dr. Alex Kudrin - Medicines and Healthcare Products Regulatory Agency (UK)8. Dr. Alex Kudrin - Medicines and Healthcare Products Regulatory Agency (UK)
8. Dr. Alex Kudrin - Medicines and Healthcare Products Regulatory Agency (UK)
 
6. Dr. Andrian Nadgyaran - Healthcare Expertise and Assessment Center (Republ...
6. Dr. Andrian Nadgyaran - Healthcare Expertise and Assessment Center (Republ...6. Dr. Andrian Nadgyaran - Healthcare Expertise and Assessment Center (Republ...
6. Dr. Andrian Nadgyaran - Healthcare Expertise and Assessment Center (Republ...
 
19. Sergey Zyrynov - Pirogov University (Russian Federation)
19. Sergey Zyrynov - Pirogov University (Russian Federation)19. Sergey Zyrynov - Pirogov University (Russian Federation)
19. Sergey Zyrynov - Pirogov University (Russian Federation)
 
Основы фармакоэкономики
Основы фармакоэкономикиОсновы фармакоэкономики
Основы фармакоэкономики
 
23. Prof. Shynar Baidullayeva - National Center for Medicines, Medical Device...
23. Prof. Shynar Baidullayeva - National Center for Medicines, Medical Device...23. Prof. Shynar Baidullayeva - National Center for Medicines, Medical Device...
23. Prof. Shynar Baidullayeva - National Center for Medicines, Medical Device...
 
Особая группа лекарственных препаратов - биоаналоги
Особая группа лекарственных препаратов - биоаналогиОсобая группа лекарственных препаратов - биоаналоги
Особая группа лекарственных препаратов - биоаналоги
 
Bubpha techapattaraporn equal partnership case studies from biotec
Bubpha techapattaraporn equal partnership case studies from biotecBubpha techapattaraporn equal partnership case studies from biotec
Bubpha techapattaraporn equal partnership case studies from biotec
 

Semelhante a Resetting Primary Care for Chronic Diseases

Lancaster General Ppt Final
Lancaster General Ppt FinalLancaster General Ppt Final
Lancaster General Ppt FinalSteven Peskin
 
World Alzheimer Report 2016: Improving healthcare for people living with deme...
World Alzheimer Report 2016: Improving healthcare for people living with deme...World Alzheimer Report 2016: Improving healthcare for people living with deme...
World Alzheimer Report 2016: Improving healthcare for people living with deme...Adelina Comas-Herrera
 
Ρητορική και πολιτική στην Πρωτοβάθμια Φροντίδα. Η αναγκαιότητα μιας τεκμηριω...
Ρητορική και πολιτική στην Πρωτοβάθμια Φροντίδα. Η αναγκαιότητα μιας τεκμηριω...Ρητορική και πολιτική στην Πρωτοβάθμια Φροντίδα. Η αναγκαιότητα μιας τεκμηριω...
Ρητορική και πολιτική στην Πρωτοβάθμια Φροντίδα. Η αναγκαιότητα μιας τεκμηριω...Evangelos Fragkoulis
 
Primary care in Europe: can we make it fit for the future?
Primary care in Europe: can we make it fit for the future?Primary care in Europe: can we make it fit for the future?
Primary care in Europe: can we make it fit for the future?Nuffield Trust
 
Clare Wilkinson - PRIME Annual Meeting 2020
Clare Wilkinson - PRIME Annual Meeting 2020Clare Wilkinson - PRIME Annual Meeting 2020
Clare Wilkinson - PRIME Annual Meeting 2020angewatkins
 
Palliative Medicine2016, Vol. 30(3) 224 –239© The Author(s
Palliative Medicine2016, Vol. 30(3) 224 –239© The Author(sPalliative Medicine2016, Vol. 30(3) 224 –239© The Author(s
Palliative Medicine2016, Vol. 30(3) 224 –239© The Author(semelyvalg9
 
World Psychiatric Association - Health Systems' Performance Roundtable cana...
World Psychiatric Association - Health Systems' Performance Roundtable   cana...World Psychiatric Association - Health Systems' Performance Roundtable   cana...
World Psychiatric Association - Health Systems' Performance Roundtable cana...Université de Montréal
 
Guidelines for Implementation of National Programme for Prevention and...
Guidelines  for  Implementation  of  National Programme  for  Prevention  and...Guidelines  for  Implementation  of  National Programme  for  Prevention  and...
Guidelines for Implementation of National Programme for Prevention and...Dr. Ankit Chaudhary
 
Population Health Planning for Chronic Disease
Population Health Planning for Chronic DiseasePopulation Health Planning for Chronic Disease
Population Health Planning for Chronic DiseaseSIMUL8 Corporation
 
eHealth_Challenges_and_Opportunities.ppt
eHealth_Challenges_and_Opportunities.ppteHealth_Challenges_and_Opportunities.ppt
eHealth_Challenges_and_Opportunities.pptAlexandruGasnas1
 
2018 Nutrition Conference: Presenter Slides
2018 Nutrition Conference:  Presenter Slides2018 Nutrition Conference:  Presenter Slides
2018 Nutrition Conference: Presenter SlidesHealth Innovation Wessex
 
Integrating NCDs and RHD in diagonal program
    Integrating   NCDs and RHD in diagonal program    Integrating   NCDs and RHD in diagonal program
Integrating NCDs and RHD in diagonal programDr. Prakash Raj Regmi
 
Human Genomics and Public Health in a Global World: Challenges for Low & Midd...
Human Genomics and Public Health in a Global World: Challenges for Low & Midd...Human Genomics and Public Health in a Global World: Challenges for Low & Midd...
Human Genomics and Public Health in a Global World: Challenges for Low & Midd...Human Variome Project
 

Semelhante a Resetting Primary Care for Chronic Diseases (20)

Lancaster General Ppt Final
Lancaster General Ppt FinalLancaster General Ppt Final
Lancaster General Ppt Final
 
World Alzheimer Report 2016: Improving healthcare for people living with deme...
World Alzheimer Report 2016: Improving healthcare for people living with deme...World Alzheimer Report 2016: Improving healthcare for people living with deme...
World Alzheimer Report 2016: Improving healthcare for people living with deme...
 
Ρητορική και πολιτική στην Πρωτοβάθμια Φροντίδα. Η αναγκαιότητα μιας τεκμηριω...
Ρητορική και πολιτική στην Πρωτοβάθμια Φροντίδα. Η αναγκαιότητα μιας τεκμηριω...Ρητορική και πολιτική στην Πρωτοβάθμια Φροντίδα. Η αναγκαιότητα μιας τεκμηριω...
Ρητορική και πολιτική στην Πρωτοβάθμια Φροντίδα. Η αναγκαιότητα μιας τεκμηριω...
 
Primary care in Europe: can we make it fit for the future?
Primary care in Europe: can we make it fit for the future?Primary care in Europe: can we make it fit for the future?
Primary care in Europe: can we make it fit for the future?
 
Clare Wilkinson - PRIME Annual Meeting 2020
Clare Wilkinson - PRIME Annual Meeting 2020Clare Wilkinson - PRIME Annual Meeting 2020
Clare Wilkinson - PRIME Annual Meeting 2020
 
Foro calidad OPIMEC Richard Smith
Foro calidad OPIMEC Richard SmithForo calidad OPIMEC Richard Smith
Foro calidad OPIMEC Richard Smith
 
Palliative Medicine2016, Vol. 30(3) 224 –239© The Author(s
Palliative Medicine2016, Vol. 30(3) 224 –239© The Author(sPalliative Medicine2016, Vol. 30(3) 224 –239© The Author(s
Palliative Medicine2016, Vol. 30(3) 224 –239© The Author(s
 
NTEP.pptx
NTEP.pptxNTEP.pptx
NTEP.pptx
 
krithiga rmnch
 krithiga rmnch krithiga rmnch
krithiga rmnch
 
R. binks healthcare policy long term conditions experiences of yorkshire
R. binks healthcare policy long term conditions experiences of yorkshireR. binks healthcare policy long term conditions experiences of yorkshire
R. binks healthcare policy long term conditions experiences of yorkshire
 
World Psychiatric Association - Health Systems' Performance Roundtable cana...
World Psychiatric Association - Health Systems' Performance Roundtable   cana...World Psychiatric Association - Health Systems' Performance Roundtable   cana...
World Psychiatric Association - Health Systems' Performance Roundtable cana...
 
Guidelines for Implementation of National Programme for Prevention and...
Guidelines  for  Implementation  of  National Programme  for  Prevention  and...Guidelines  for  Implementation  of  National Programme  for  Prevention  and...
Guidelines for Implementation of National Programme for Prevention and...
 
Population Health Planning for Chronic Disease
Population Health Planning for Chronic DiseasePopulation Health Planning for Chronic Disease
Population Health Planning for Chronic Disease
 
eHealth_Challenges_and_Opportunities.ppt
eHealth_Challenges_and_Opportunities.ppteHealth_Challenges_and_Opportunities.ppt
eHealth_Challenges_and_Opportunities.ppt
 
Foro calidad OPIMEC Renée Lyons
Foro calidad OPIMEC Renée LyonsForo calidad OPIMEC Renée Lyons
Foro calidad OPIMEC Renée Lyons
 
2018 Nutrition Conference: Presenter Slides
2018 Nutrition Conference:  Presenter Slides2018 Nutrition Conference:  Presenter Slides
2018 Nutrition Conference: Presenter Slides
 
Integrating NCDs and RHD in diagonal program
    Integrating   NCDs and RHD in diagonal program    Integrating   NCDs and RHD in diagonal program
Integrating NCDs and RHD in diagonal program
 
Kevin Fenton
Kevin FentonKevin Fenton
Kevin Fenton
 
Npcdcs ppt
Npcdcs pptNpcdcs ppt
Npcdcs ppt
 
Human Genomics and Public Health in a Global World: Challenges for Low & Midd...
Human Genomics and Public Health in a Global World: Challenges for Low & Midd...Human Genomics and Public Health in a Global World: Challenges for Low & Midd...
Human Genomics and Public Health in a Global World: Challenges for Low & Midd...
 

Mais de International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Mais de International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) (20)

Peter Hotez, Baylor College of Medicine
Peter Hotez,  Baylor College of MedicinePeter Hotez,  Baylor College of Medicine
Peter Hotez, Baylor College of Medicine
 
Session1: Patrick Deboyser, European Union
Session1: Patrick Deboyser, European UnionSession1: Patrick Deboyser, European Union
Session1: Patrick Deboyser, European Union
 
Session 4: Bejon Misra Partnership for Safe Medicines (PSM) INDIA /
Session 4: Bejon Misra Partnership for Safe Medicines (PSM) INDIA / Session 4: Bejon Misra Partnership for Safe Medicines (PSM) INDIA /
Session 4: Bejon Misra Partnership for Safe Medicines (PSM) INDIA /
 
Session 4 Sabine Walser Council of Europe / Legal framework necessary for eff...
Session 4 Sabine Walser Council of Europe / Legal framework necessary for eff...Session 4 Sabine Walser Council of Europe / Legal framework necessary for eff...
Session 4 Sabine Walser Council of Europe / Legal framework necessary for eff...
 
Session 4: Domenico Di Giorgio AIFA Italy / SPOC model cooperation against co...
Session 4: Domenico Di Giorgio AIFA Italy / SPOC model cooperation against co...Session 4: Domenico Di Giorgio AIFA Italy / SPOC model cooperation against co...
Session 4: Domenico Di Giorgio AIFA Italy / SPOC model cooperation against co...
 
Session 3: Salmah Bahri - Ministry of Health, Malaysia / Monitoring of Counte...
Session 3: Salmah Bahri - Ministry of Health, Malaysia / Monitoring of Counte...Session 3: Salmah Bahri - Ministry of Health, Malaysia / Monitoring of Counte...
Session 3: Salmah Bahri - Ministry of Health, Malaysia / Monitoring of Counte...
 
Session 4: Sheuan Lee, International Council of Nurses (ICN) / Practices and ...
Session 4: Sheuan Lee, International Council of Nurses (ICN) / Practices and ...Session 4: Sheuan Lee, International Council of Nurses (ICN) / Practices and ...
Session 4: Sheuan Lee, International Council of Nurses (ICN) / Practices and ...
 
Session 3: Ivan Ho Pfizer / Counterfeit Medicines Threat to Patient Health an...
Session 3: Ivan Ho Pfizer / Counterfeit Medicines Threat to Patient Health an...Session 3: Ivan Ho Pfizer / Counterfeit Medicines Threat to Patient Health an...
Session 3: Ivan Ho Pfizer / Counterfeit Medicines Threat to Patient Health an...
 
Session 3: Fu-Wen Chang, nternational Federation of Pharmaceutical Wholesaler...
Session 3: Fu-Wen Chang, nternational Federation of Pharmaceutical Wholesaler...Session 3: Fu-Wen Chang, nternational Federation of Pharmaceutical Wholesaler...
Session 3: Fu-Wen Chang, nternational Federation of Pharmaceutical Wholesaler...
 
Afternoon Session Opening: Jim Dahl, Partnership for Safe Medicines
Afternoon Session Opening: Jim Dahl, Partnership for Safe MedicinesAfternoon Session Opening: Jim Dahl, Partnership for Safe Medicines
Afternoon Session Opening: Jim Dahl, Partnership for Safe Medicines
 
Session 2: Mike Rose, Johnson & Johnson / Serialization and Traceability GS1 ...
Session 2: Mike Rose, Johnson & Johnson / Serialization and Traceability GS1 ...Session 2: Mike Rose, Johnson & Johnson / Serialization and Traceability GS1 ...
Session 2: Mike Rose, Johnson & Johnson / Serialization and Traceability GS1 ...
 
Session 2: Scott Kammer, Rx360
Session 2: Scott Kammer, Rx360 Session 2: Scott Kammer, Rx360
Session 2: Scott Kammer, Rx360
 
Opening Session - Cyntia Genole, IFPMA
Opening Session - Cyntia Genole, IFPMAOpening Session - Cyntia Genole, IFPMA
Opening Session - Cyntia Genole, IFPMA
 
Session 1 - Mark Paxton, US FDA / APEC Roadmap to Promote Global Medical Prod...
Session 1 - Mark Paxton, US FDA / APEC Roadmap to Promote Global Medical Prod...Session 1 - Mark Paxton, US FDA / APEC Roadmap to Promote Global Medical Prod...
Session 1 - Mark Paxton, US FDA / APEC Roadmap to Promote Global Medical Prod...
 
Bringing Psoriasis into the Light, Kim kjoeller, Leo Pharma
Bringing Psoriasis into the Light, Kim kjoeller, Leo PharmaBringing Psoriasis into the Light, Kim kjoeller, Leo Pharma
Bringing Psoriasis into the Light, Kim kjoeller, Leo Pharma
 
IFPA Psoriasis Presentation
IFPA Psoriasis PresentationIFPA Psoriasis Presentation
IFPA Psoriasis Presentation
 
International Psoriasis Council, Steve O'Dell
International Psoriasis Council, Steve O'DellInternational Psoriasis Council, Steve O'Dell
International Psoriasis Council, Steve O'Dell
 
Manaement of Psoriasis in Low Income Countries
Manaement of Psoriasis in Low Income CountriesManaement of Psoriasis in Low Income Countries
Manaement of Psoriasis in Low Income Countries
 
IFPMA: From Manufacturing to the Vaccinee – the Complex Journey of a Vaccine
IFPMA: From Manufacturing to the Vaccinee – the Complex Journey of a VaccineIFPMA: From Manufacturing to the Vaccinee – the Complex Journey of a Vaccine
IFPMA: From Manufacturing to the Vaccinee – the Complex Journey of a Vaccine
 
The Complex Journey of a Vaccine
The Complex Journey of a VaccineThe Complex Journey of a Vaccine
The Complex Journey of a Vaccine
 

Resetting Primary Care for Chronic Diseases

  • 1. Reconfiguring primary care for the era of chronic diseases Margaret E. Kruk, MD MPH Columbia University Mailman School of Public Health February 4, 2013
  • 2. A few numbers • 44 million • 80% • 1 in 3 1
  • 3. A few numbers • 44 million deaths from CVD, diabetes, cancer, chronic respiratory disease in 2010 • 80% of NCD deaths in low- and middle income countries • 1 in 3 NCD deaths in LMICs are under the age of 60 2
  • 4. Shifting epidemiology: Brazil 1930-2004 PAHO/WHO. Scaling up Primary Health Care Interventions for Chronic Disease Prevention and Control. 35th Annual International Conference of the Global Health Council. Washington, DC: PAHO/WHO; 2008. 3
  • 5. Primary care • first-contact care • promotes ease of access • care for a broad range of health needs • continuity • involvement of family and community 4
  • 6. Primary care • first-contact care • promotes ease of access Ideal • care for a broad range of platform health needs for • continuity tackling NCDs • involvement of family and community 5
  • 7. Many NCD services can be provided in primary care • Primary prevention: Hepatitis B and HPV immunization, smoking cessation • Diagnosis: BP, cholesterol, glucose testing, mammography, opportunistic screening for depression 6
  • 8. Many NCD services can be provided in primary care • Management: CVD therapy, inhaled corticosteroids/beta-2 agonists, hypoglycemics, antidepressants, retinopathy screening • Palliation: home-based care for terminal cancer, opiate therapy 7
  • 9. But primary care in LMICs not able to meet NCD challenge Historic orientation to infectious diseases and maternal and child health 8
  • 10. But primary care in LMICs not able to meet NCD challenge Chronic underfunding and human resource crisis 9
  • 11. The NCD imperative • Integration and continuity of care • Innovative service delivery • Inclusion of patients and communities • Information and communication and • Evaluation for accountability 10
  • 12. Integration and continuity • Reorganize of care delivery with patient as the central node • Move from vertical programming to investing in health systems • Borrow from HIV care: a chronic, communicable disease • Team based care (e.g., Brazil’s family health teams) • Integration with referral care 11
  • 13. Innovative service delivery • Shift tasks to non-physicians (Cameroon’s nurse-led CVD program) • Use algorithms and clinical guidelines • Diagnose at the point of care (e.g., Peru’s see and treat cervical cancer screening) 12
  • 14. Inclusion of patients and communities • Reduce financial barriers to care for NCDs (e.g., diabetes in Cameroon, CCTs in Mexico) • Improve fit between patient expectations and reality in health service provision • Reach out to community and engage peers 13
  • 15. Information and communication • Use mobile phones to promote healthy lifestyles (e.g., smoking cessation in Britain) • Use mobile and internet technology to bridge distance between home and primary health clinic (e.g., text test results, appt reminders) 14
  • 16. Evaluation is a crucial underpinning • Learning what works across different settings • Making necessary course corrections • Enhancing accountability to funders and patients 15
  • 17. Need for a reset of primary care to realize its potential to tackle NCDs in low- and middle- income countries 16